Andouard, D <br/><br/>
Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis.  [electronic resource] 

 -  Antiviral research  May 2016 
 - 115-119 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-9096 
<br/><br/><label>Standard No.: </label>10.1016/j.antiviral.2016.02.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--pharmacology<br/>Chromosomes, Artificial, Bacterial<br/>Cytomegalovirus--drug effects<br/>Cytosine--pharmacology<br/>DNA, Viral--genetics<br/>DNA-Directed DNA Polymerase--chemistry<br/>Drug Resistance, Viral<br/>Foscarnet--pharmacology<br/>Ganciclovir--pharmacology<br/>Humans<br/>Models, Molecular<br/>Mutagenesis<br/>Organophosphonates--pharmacology<br/>Phenotype<br/>Point Mutation<br/>Protein Domains<br/>Viral Proteins--chemistry